Listed

Cardinal Health Inc

CAHNYSECIK 721371Consumer discretionaryFiscal year ends Jun 30

Latest reported revenue, Q2 FY2026$65.63bnRevenue, Q2 FY2026, three months to 2025-12-31$65.63bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-02-05, accession 0000721371-26-000006.Report this figureThree months to Dec 31, 2025, from the 10-Q filed Feb 5, 2026.

Latest quarter: Q2 FY2026

Three months to Dec 31, 2025, against the same quarter a year earlier.

  • Revenue$65.63bnRevenue, Q2 FY2026, three months to 2025-12-31$65.63bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-02-05, accession 0000721371-26-000006.Report this figure+18.8% on a year earlier
  • Gross margin3.7%Gross margin, Q2 FY2026, three months to 2025-12-31. gross profit / revenueGross profit: $2.40bn. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-02-05, accession 0000721371-26-000006.Revenue: $65.63bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-02-05, accession 0000721371-26-000006.Report this figure+0.1 pts on a year earlier
  • Operating margin1.1%Operating margin, Q2 FY2026, three months to 2025-12-31. operating income / revenueOperating income: $707.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-05, accession 0000721371-26-000006.Revenue: $65.63bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-02-05, accession 0000721371-26-000006.Report this figure+0.1 pts on a year earlier
  • Net margin0.7%Net margin, Q2 FY2026, three months to 2025-12-31. net income / revenueNet income: $467.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-05, accession 0000721371-26-000006.Revenue: $65.63bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-02-05, accession 0000721371-26-000006.Report this figure−0.0 pts on a year earlier
  • Diluted EPSnot reported (Diluted EPS not reported)No year-earlier figure to compare
  • Free cash flow$555.0mFree cash flow, Q2 FY2026, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $686.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-05, accession 0000721371-26-000006. Derived: 6-month figure less the 3-month figure.Capital expenditure: $131.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-02-05, accession 0000721371-26-000006. Derived: 6-month figure less the 3-month figure.Report this figureSign changed from a year earlier

Last eight quarters

Full statements
Revenue$65.63bnGross margin 3.7%
Diluted EPS$1.88, Q1 FY2026
Free cash flow$555.0m, Q2 FY2026
Cardinal Health Inc, key figures for the last eight quarters
Line itemUnitQ3 FY20242024-03-31Q4 FY20242024-06-30Q1 FY20252024-09-30Q2 FY20252024-12-31Q3 FY20252025-03-31Q4 FY20252025-06-30Q1 FY20262025-09-30Q2 FY20262025-12-31Shape over the periods
Revenue$bn54.9Revenue, Q3 FY2024, three months to 2024-03-31$54.87bn. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-01, accession 0000721371-25-000038.Report this figure59.9Revenue, Q4 FY2024, three months to 2024-06-30$59.87bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-08-11, accession 0000721371-26-000038. Derived: 12-month figure less the 9-month figure.Report this figure52.3Revenue, Q1 FY2025, three months to 2024-09-30$52.28bn. XBRL concept us-gaap:Revenues. 10-Q filed 2025-10-30, accession 0000721371-25-000130.Report this figure55.3Revenue, Q2 FY2025, three months to 2024-12-31$55.26bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-02-05, accession 0000721371-26-000006.Report this figure54.9Revenue, Q3 FY2025, three months to 2025-03-31$54.88bn. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-01, accession 0000721371-25-000038.Report this figure60.2Revenue, Q4 FY2025, three months to 2025-06-30$60.16bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-08-11, accession 0000721371-26-000038. Derived: 12-month figure less the 9-month figure.Report this figure64.0Revenue, Q1 FY2026, three months to 2025-09-30$64.01bn. XBRL concept us-gaap:Revenues. 10-Q filed 2025-10-30, accession 0000721371-25-000130.Report this figure65.6Revenue, Q2 FY2026, three months to 2025-12-31$65.63bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-02-05, accession 0000721371-26-000006.Report this figure
Gross margin%3.5%Gross margin, Q3 FY2024, three months to 2024-03-31. gross profit / revenueGross profit: $1.94bn. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-01, accession 0000721371-25-000038.Revenue: $54.87bn. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-01, accession 0000721371-25-000038.Report this figure3.1%Gross margin, Q4 FY2024, three months to 2024-06-30. gross profit / revenueGross profit: $1.88bn. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-08-11, accession 0000721371-26-000038. Derived: 12-month figure less the 9-month figure.Revenue: $59.87bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-08-11, accession 0000721371-26-000038. Derived: 12-month figure less the 9-month figure.Report this figure3.6%Gross margin, Q1 FY2025, three months to 2024-09-30. gross profit / revenueGross profit: $1.90bn. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-10-30, accession 0000721371-25-000130.Revenue: $52.28bn. XBRL concept us-gaap:Revenues. 10-Q filed 2025-10-30, accession 0000721371-25-000130.Report this figure3.5%Gross margin, Q2 FY2025, three months to 2024-12-31. gross profit / revenueGross profit: $1.94bn. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-02-05, accession 0000721371-26-000006.Revenue: $55.26bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-02-05, accession 0000721371-26-000006.Report this figure3.9%Gross margin, Q3 FY2025, three months to 2025-03-31. gross profit / revenueGross profit: $2.12bn. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-01, accession 0000721371-25-000038.Revenue: $54.88bn. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-01, accession 0000721371-25-000038.Report this figure3.7%Gross margin, Q4 FY2025, three months to 2025-06-30. gross profit / revenueGross profit: $2.20bn. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-08-11, accession 0000721371-26-000038. Derived: 12-month figure less the 9-month figure.Revenue: $60.16bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-08-11, accession 0000721371-26-000038. Derived: 12-month figure less the 9-month figure.Report this figure3.6%Gross margin, Q1 FY2026, three months to 2025-09-30. gross profit / revenueGross profit: $2.32bn. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-10-30, accession 0000721371-25-000130.Revenue: $64.01bn. XBRL concept us-gaap:Revenues. 10-Q filed 2025-10-30, accession 0000721371-25-000130.Report this figure3.7%Gross margin, Q2 FY2026, three months to 2025-12-31. gross profit / revenueGross profit: $2.40bn. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-02-05, accession 0000721371-26-000006.Revenue: $65.63bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-02-05, accession 0000721371-26-000006.Report this figure
Operating margin%0.7%Operating margin, Q3 FY2024, three months to 2024-03-31. operating income / revenueOperating income: $369.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-01, accession 0000721371-25-000038.Revenue: $54.87bn. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-01, accession 0000721371-25-000038.Report this figure0.7%Operating margin, Q4 FY2024, three months to 2024-06-30. operating income / revenueOperating income: $401.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-08-11, accession 0000721371-26-000038. Derived: 12-month figure less the 9-month figure.Revenue: $59.87bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-08-11, accession 0000721371-26-000038. Derived: 12-month figure less the 9-month figure.Report this figure1.1%Operating margin, Q1 FY2025, three months to 2024-09-30. operating income / revenueOperating income: $568.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-30, accession 0000721371-25-000130.Revenue: $52.28bn. XBRL concept us-gaap:Revenues. 10-Q filed 2025-10-30, accession 0000721371-25-000130.Report this figure1.0%Operating margin, Q2 FY2025, three months to 2024-12-31. operating income / revenueOperating income: $549.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-05, accession 0000721371-26-000006.Revenue: $55.26bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-02-05, accession 0000721371-26-000006.Report this figure1.3%Operating margin, Q3 FY2025, three months to 2025-03-31. operating income / revenueOperating income: $730.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-01, accession 0000721371-25-000038.Revenue: $54.88bn. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-01, accession 0000721371-25-000038.Report this figure0.7%Operating margin, Q4 FY2025, three months to 2025-06-30. operating income / revenueOperating income: $428.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-08-11, accession 0000721371-26-000038. Derived: 12-month figure less the 9-month figure.Revenue: $60.16bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-08-11, accession 0000721371-26-000038. Derived: 12-month figure less the 9-month figure.Report this figure1.0%Operating margin, Q1 FY2026, three months to 2025-09-30. operating income / revenueOperating income: $668.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-30, accession 0000721371-25-000130.Revenue: $64.01bn. XBRL concept us-gaap:Revenues. 10-Q filed 2025-10-30, accession 0000721371-25-000130.Report this figure1.1%Operating margin, Q2 FY2026, three months to 2025-12-31. operating income / revenueOperating income: $707.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-05, accession 0000721371-26-000006.Revenue: $65.63bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-02-05, accession 0000721371-26-000006.Report this figure
Net margin%0.5%Net margin, Q3 FY2024, three months to 2024-03-31. net income / revenueNet income: $261.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-01, accession 0000721371-25-000038.Revenue: $54.87bn. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-01, accession 0000721371-25-000038.Report this figure0.4%Net margin, Q4 FY2024, three months to 2024-06-30. net income / revenueNet income: $235.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-08-11, accession 0000721371-26-000038. Derived: 12-month figure less the 9-month figure.Revenue: $59.87bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-08-11, accession 0000721371-26-000038. Derived: 12-month figure less the 9-month figure.Report this figure0.8%Net margin, Q1 FY2025, three months to 2024-09-30. net income / revenueNet income: $416.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-30, accession 0000721371-25-000130.Revenue: $52.28bn. XBRL concept us-gaap:Revenues. 10-Q filed 2025-10-30, accession 0000721371-25-000130.Report this figure0.7%Net margin, Q2 FY2025, three months to 2024-12-31. net income / revenueNet income: $400.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-05, accession 0000721371-26-000006.Revenue: $55.26bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-02-05, accession 0000721371-26-000006.Report this figure0.9%Net margin, Q3 FY2025, three months to 2025-03-31. net income / revenueNet income: $506.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-01, accession 0000721371-25-000038.Revenue: $54.88bn. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-01, accession 0000721371-25-000038.Report this figure0.4%Net margin, Q4 FY2025, three months to 2025-06-30. net income / revenueNet income: $239.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-08-11, accession 0000721371-26-000038. Derived: 12-month figure less the 9-month figure.Revenue: $60.16bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-08-11, accession 0000721371-26-000038. Derived: 12-month figure less the 9-month figure.Report this figure0.7%Net margin, Q1 FY2026, three months to 2025-09-30. net income / revenueNet income: $450.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-30, accession 0000721371-25-000130.Revenue: $64.01bn. XBRL concept us-gaap:Revenues. 10-Q filed 2025-10-30, accession 0000721371-25-000130.Report this figure0.7%Net margin, Q2 FY2026, three months to 2025-12-31. net income / revenueNet income: $467.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-05, accession 0000721371-26-000006.Revenue: $65.63bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-02-05, accession 0000721371-26-000006.Report this figure
Diluted EPS$ per share1.07Diluted EPS, Q3 FY2024, three months to 2024-03-31$1.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-08-14, accession 0000721371-24-000056.Report this figurenot reported (Diluted EPS not reported)1.70Diluted EPS, Q1 FY2025, three months to 2024-09-30$1.70 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-30, accession 0000721371-25-000130.Report this figurenot reported (Diluted EPS not reported)not reported (Diluted EPS not reported)not reported (Diluted EPS not reported)1.88Diluted EPS, Q1 FY2026, three months to 2025-09-30$1.88 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-30, accession 0000721371-25-000130.Report this figurenot reported (Diluted EPS not reported)
Free cash flow$bn(0.1)Free cash flow, Q3 FY2024, three months to 2024-03-31. operating cash flow − capital expenditureOperating cash flow: −$27.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-01, accession 0000721371-25-000038. Derived: 9-month figure less the 6-month figure.Capital expenditure: $112.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-01, accession 0000721371-25-000038. Derived: 9-month figure less the 6-month figure.Report this figure1.9Free cash flow, Q4 FY2024, three months to 2024-06-30. operating cash flow − capital expenditureOperating cash flow: $2.08bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-08-11, accession 0000721371-26-000038. Derived: 12-month figure less the 9-month figure.Capital expenditure: $193.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-08-11, accession 0000721371-26-000038. Derived: 12-month figure less the 9-month figure.Report this figure(1.7)Free cash flow, Q1 FY2025, three months to 2024-09-30. operating cash flow − capital expenditureOperating cash flow: −$1.65bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-30, accession 0000721371-25-000130.Capital expenditure: $90.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-30, accession 0000721371-25-000130.Report this figure(0.5)Free cash flow, Q2 FY2025, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: −$396.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-05, accession 0000721371-26-000006. Derived: 6-month figure less the 3-month figure.Capital expenditure: $99.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-02-05, accession 0000721371-26-000006. Derived: 6-month figure less the 3-month figure.Report this figure2.8Free cash flow, Q3 FY2025, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: $2.91bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-01, accession 0000721371-25-000038. Derived: 9-month figure less the 6-month figure.Capital expenditure: $126.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-01, accession 0000721371-25-000038. Derived: 9-month figure less the 6-month figure.Report this figure1.3Free cash flow, Q4 FY2025, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: $1.53bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-08-11, accession 0000721371-26-000038. Derived: 12-month figure less the 9-month figure.Capital expenditure: $232.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-08-11, accession 0000721371-26-000038. Derived: 12-month figure less the 9-month figure.Report this figure0.9Free cash flow, Q1 FY2026, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: $973.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-30, accession 0000721371-25-000130.Capital expenditure: $108.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-30, accession 0000721371-25-000130.Report this figure0.6Free cash flow, Q2 FY2026, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $686.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-05, accession 0000721371-26-000006. Derived: 6-month figure less the 3-month figure.Capital expenditure: $131.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-02-05, accession 0000721371-26-000006. Derived: 6-month figure less the 3-month figure.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$254.25bnGross margin 3.8%
Diluted EPS$7.23, FY2026
Free cash flow$4.53bn, FY2026
Cardinal Health Inc, key figures for the last five fiscal years
Line itemUnitFY20222022-06-30FY20232023-06-30FY20242024-06-30FY20252025-06-30FY20262026-06-30Shape over the periods
Revenue$bn181Revenue, FY2022, twelve months to 2022-06-30$181.33bn. XBRL concept us-gaap:Revenues. 10-K filed 2024-08-14, accession 0000721371-24-000056.Report this figure205Revenue, FY2023, twelve months to 2023-06-30$204.98bn. XBRL concept us-gaap:Revenues. 10-K filed 2025-08-12, accession 0000721371-25-000079.Report this figure227Revenue, FY2024, twelve months to 2024-06-30$226.83bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-08-11, accession 0000721371-26-000038.Report this figure223Revenue, FY2025, twelve months to 2025-06-30$222.58bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-08-11, accession 0000721371-26-000038.Report this figure254Revenue, FY2026, twelve months to 2026-06-30$254.25bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-08-11, accession 0000721371-26-000038.Report this figure
Gross margin%3.6%Gross margin, FY2022, twelve months to 2022-06-30. gross profit / revenueGross profit: $6.48bn. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-08-14, accession 0000721371-24-000056.Revenue: $181.33bn. XBRL concept us-gaap:Revenues. 10-K filed 2024-08-14, accession 0000721371-24-000056.Report this figure3.4%Gross margin, FY2023, twelve months to 2023-06-30. gross profit / revenueGross profit: $6.87bn. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-08-12, accession 0000721371-25-000079.Revenue: $204.98bn. XBRL concept us-gaap:Revenues. 10-K filed 2025-08-12, accession 0000721371-25-000079.Report this figure3.3%Gross margin, FY2024, twelve months to 2024-06-30. gross profit / revenueGross profit: $7.41bn. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-08-11, accession 0000721371-26-000038.Revenue: $226.83bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-08-11, accession 0000721371-26-000038.Report this figure3.7%Gross margin, FY2025, twelve months to 2025-06-30. gross profit / revenueGross profit: $8.17bn. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-08-11, accession 0000721371-26-000038.Revenue: $222.58bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-08-11, accession 0000721371-26-000038.Report this figure3.8%Gross margin, FY2026, twelve months to 2026-06-30. gross profit / revenueGross profit: $9.77bn. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-08-11, accession 0000721371-26-000038.Revenue: $254.25bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-08-11, accession 0000721371-26-000038.Report this figure
Operating margin%(0.3%)Operating margin, FY2022, twelve months to 2022-06-30. operating income / revenueOperating income: −$607.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-08-14, accession 0000721371-24-000056.Revenue: $181.33bn. XBRL concept us-gaap:Revenues. 10-K filed 2024-08-14, accession 0000721371-24-000056.Report this figure0.4%Operating margin, FY2023, twelve months to 2023-06-30. operating income / revenueOperating income: $752.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-08-12, accession 0000721371-25-000079.Revenue: $204.98bn. XBRL concept us-gaap:Revenues. 10-K filed 2025-08-12, accession 0000721371-25-000079.Report this figure0.5%Operating margin, FY2024, twelve months to 2024-06-30. operating income / revenueOperating income: $1.24bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-08-11, accession 0000721371-26-000038.Revenue: $226.83bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-08-11, accession 0000721371-26-000038.Report this figure1.0%Operating margin, FY2025, twelve months to 2025-06-30. operating income / revenueOperating income: $2.27bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-08-11, accession 0000721371-26-000038.Revenue: $222.58bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-08-11, accession 0000721371-26-000038.Report this figure1.0%Operating margin, FY2026, twelve months to 2026-06-30. operating income / revenueOperating income: $2.61bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-08-11, accession 0000721371-26-000038.Revenue: $254.25bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-08-11, accession 0000721371-26-000038.Report this figure
Net margin%(0.5%)Net margin, FY2022, twelve months to 2022-06-30. net income / revenueNet income: −$938.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-08-14, accession 0000721371-24-000056.Revenue: $181.33bn. XBRL concept us-gaap:Revenues. 10-K filed 2024-08-14, accession 0000721371-24-000056.Report this figure0.2%Net margin, FY2023, twelve months to 2023-06-30. net income / revenueNet income: $330.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-08-12, accession 0000721371-25-000079.Revenue: $204.98bn. XBRL concept us-gaap:Revenues. 10-K filed 2025-08-12, accession 0000721371-25-000079.Report this figure0.4%Net margin, FY2024, twelve months to 2024-06-30. net income / revenueNet income: $852.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-08-11, accession 0000721371-26-000038.Revenue: $226.83bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-08-11, accession 0000721371-26-000038.Report this figure0.7%Net margin, FY2025, twelve months to 2025-06-30. net income / revenueNet income: $1.56bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-08-11, accession 0000721371-26-000038.Revenue: $222.58bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-08-11, accession 0000721371-26-000038.Report this figure0.7%Net margin, FY2026, twelve months to 2026-06-30. net income / revenueNet income: $1.71bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-08-11, accession 0000721371-26-000038.Revenue: $254.25bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-08-11, accession 0000721371-26-000038.Report this figure
Diluted EPS$ per share(3.37)Diluted EPS, FY2022, twelve months to 2022-06-30−$3.37 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-08-14, accession 0000721371-24-000056.Report this figure1.26Diluted EPS, FY2023, twelve months to 2023-06-30$1.26 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-08-12, accession 0000721371-25-000079.Report this figure3.45Diluted EPS, FY2024, twelve months to 2024-06-30$3.45 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-08-11, accession 0000721371-26-000038.Report this figure6.45Diluted EPS, FY2025, twelve months to 2025-06-30$6.45 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-08-11, accession 0000721371-26-000038.Report this figure7.23Diluted EPS, FY2026, twelve months to 2026-06-30$7.23 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-08-11, accession 0000721371-26-000038.Report this figure
Free cash flow$bn2.8Free cash flow, FY2022, twelve months to 2022-06-30. operating cash flow − capital expenditureOperating cash flow: $3.17bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-08-14, accession 0000721371-24-000056.Capital expenditure: $387.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-08-14, accession 0000721371-24-000056.Report this figure2.4Free cash flow, FY2023, twelve months to 2023-06-30. operating cash flow − capital expenditureOperating cash flow: $2.84bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-08-12, accession 0000721371-25-000079.Capital expenditure: $481.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-08-12, accession 0000721371-25-000079.Report this figure3.3Free cash flow, FY2024, twelve months to 2024-06-30. operating cash flow − capital expenditureOperating cash flow: $3.76bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-08-11, accession 0000721371-26-000038.Capital expenditure: $511.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-08-11, accession 0000721371-26-000038.Report this figure1.9Free cash flow, FY2025, twelve months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: $2.40bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-08-11, accession 0000721371-26-000038.Capital expenditure: $547.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-08-11, accession 0000721371-26-000038.Report this figure4.5Free cash flow, FY2026, twelve months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $5.17bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-08-11, accession 0000721371-26-000038.Capital expenditure: $649.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-08-11, accession 0000721371-26-000038.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Cardinal Health Inc
FundQuarter endedReported valueSharesPut or callChange on the quarter before
BlackRock, Inc.2026-06-30$6.29bn26,490,633Reduced−2,004,222
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$3.63bn15,292,186Added+3,477
WELLINGTON MANAGEMENT GROUP LLP2026-06-30$3.53bn14,860,271Added+10,584,119
VANGUARD PORTFOLIO MANAGEMENT LLC2026-06-30$3.26bn13,717,894Reduced−14,415
STATE STREET CORP2026-06-30$2.84bn11,967,121Reduced−107,397
GEODE CAPITAL MANAGEMENT, LLC2026-06-30$1.53bn6,472,810Reduced−107,722
Invesco Ltd.2026-06-30$1.13bn4,742,576Added+1,230,335
MORGAN STANLEY2026-06-30$1.10bn4,625,329Reduced−328,999
WCM INVESTMENT MANAGEMENT, LLC2026-06-30$971.4m4,112,461Added+105,825
NORGES BANK2026-06-30$885.2m3,726,422New+3,726,422

Recent filings

All 1,604 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Cardinal Health Inc, recent filings
FiledFormWhat it isAccession number
2026-10-0110:52 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000721371-26-000041
2026-09-2120:15 ETDEF 14AProxy statementPeriod 2026-11-120001308179-26-000402
2026-08-1112:57 ET10-KAnnual reportPeriod 2026-06-300000721371-26-000038
2026-08-1110:47 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000721371-26-000037
2026-08-1110:38 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0000721371-26-000036
2026-08-0510:39 ET8-K5.02 Departure or appointment of officers or directors0000721371-26-000026
2026-04-3012:51 ET10-QQuarterly reportPeriod 2026-03-310000721371-26-000018
2026-04-3010:47 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000721371-26-000017
2026-03-2310:48 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000721371-26-000013
2026-03-0512:07 ET8-K5.02 Departure or appointment of officers or directors0000721371-26-000010

Latest annual report

Form 10-K for the fiscal year ended Jun 30, 2026Filed Aug 11, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Not in this season’s league. The league lists companies whose quarter has ended and whose results are not yet filed.This season’s league

About the filer

CIK
721371
Tickers
CAH
Exchange
NYSE
SIC code
5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries
Sector
Consumer discretionary
Fiscal year ends
Jun 30
Incorporated in
OH
Filer category
Large accelerated filer
Former names
CARDINAL HEALTH INC (to 2026-10-01); CARDINAL DISTRIBUTION INC (to 1994-02-17)

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:23 ET. Listed shows no prices and gives no investment advice.